Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Regulation Approvals

New Products In Brief

This article was originally published in The Gray Sheet

  • News

Executive Summary

AtriCure’s Synergy surgical ablation system for atrial fibrillation and J&J/DePuy’s next-generation polyethylene bearing for rotating platform and mobile bearing knees gain PMA approvals. More new products.

You may also be interested in...



New Product Briefs: Orthopedic Devices; Point-Of-Care Cardiac Assay; Auto-Injector

Orthopedics launches from Integra LifeSciences, Amedica and DePuy Synthes CMF. Also, product announcements from Critical Diagnostics and Antares Pharma.

People In Brief

Michael F. Mahoney succeeds William H. Kucheman as CEO of Boston Scientific, while CardioInsight Technologies, HiberGene Diagnostics and AtriCure appoint new CEOs.

People In Brief

Transitions at the top at Varian, Altura and more.

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Medtech Insight

Topics

Related Companies

Tags:
Medical Device Regulation Approvals
Latest Headlines

Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel

Philips Portfolio Includes ‘No Single Product That Does Not Use A Type Of AI,’ Says CEO And AI Thought Leader Roy Jakobs

More Heartmate Troubles For Abbott. Latest Recall Includes 14 Deaths

Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests

See All
UsernamePublicRestriction

Register

MT030821

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By